speb/financial-data huggingface dataset:
Financial ratios for CDIO — quarterly report dated 2025-09-30
Total revenue: 2855
Operating income: -1711597
Net income: -1714536
Capital expenditures: 162834
Operating cash flow: -1393418
Depreciation & amortization: 89588
Net tangible assets: 7351093
Owner earnings: -1787782
Return on net tangible assets (%): -24.319948067586683
Buffett classification: The Gruesome
Stock price: 4.01
Shares outstanding: 2959469
Book value: 8151571
P/B ratio: 1.4558507421452869
Market cap (USD): 11867470.69
Debt to equity: 0.059693646782933006
Current ratio: 17.386138216279164
Quick ratio: 17.386138216279164
Interest coverage ratio: -547.1857416879795
COGS to revenue (%): 0
R&D to revenue (%): 6621.681260945709
SG&A to revenue (%): 53231.10332749562
Free cash flow (dilution-adjusted): -1675999
Buyback yield (%): 0
Retained earnings: -27784632
Receivables turnover: 0.25443365118973355
Capitalized R&D asset: 228247.72
ROCI (R&D-adjusted, %): -18.85619264707539
FCF margin (%): -58703.992994746055
Revenue growth (%): -61.80602006688963
Rule of 40 score: -58765.79901481295
Financial ratios for CDIO — quarterly report dated 2025-12-31
Total revenue: 3555
Operating income: -1463222
Net income: -1465368
Capital expenditures: 0
Operating cash flow: -1361849
Depreciation & amortization: 94077
Net tangible assets: 6100172
Owner earnings: -1371291
Return on net tangible assets (%): -22.479546478361595
Buffett classification: The Gruesome
Stock price: 2.71
Shares outstanding: 2959469
Book value: 6973354
P/B ratio: 1.1501152802510815
Market cap (USD): 8020160.99
Debt to equity: 0.09975386306216492
Current ratio: 9.788890927999022
Quick ratio: 9.788890927999022
Interest coverage ratio: -638.4040139616055
COGS to revenue (%): 0
R&D to revenue (%): 8069.395218002814
SG&A to revenue (%): 33031.082981715896
Free cash flow (dilution-adjusted): -1464291
Buyback yield (%): 0
Retained earnings: -29250000
Receivables turnover: 0.43748461727787347
Capitalized R&D asset: 413529.83
ROCI (R&D-adjusted, %): -17.62343255165673
FCF margin (%): -41189.620253164554
Revenue growth (%): 24.518388791593697
Rule of 40 score: -41165.10186437296
Financial ratios for CDIO — annual report dated 2025-12-31
Total revenue: 14825
Operating income: -6484078
Net income: -6498167
Capital expenditures: 187317
Operating cash flow: -5726833
Depreciation & amortization: 398128
Net tangible assets: 6100172
Owner earnings: -6287356
Return on net tangible assets (%): -103.06850364219238
Buffett classification: The Gruesome
Stock price: 2.71
Shares outstanding: 2959469
Book value: 6973354
P/B ratio: 1.1501152802510815
Market cap (USD): 8020160.99
Debt to equity: 0.09975386306216492
Current ratio: 9.788890927999022
Quick ratio: 9.788890927999022
Interest coverage ratio: -438.0837781230998
COGS to revenue (%): 0
R&D to revenue (%): 4325.207419898819
SG&A to revenue (%): 39072.22934232715
Free cash flow (dilution-adjusted): -6256378
Buyback yield (%): 0
Retained earnings: -29250000
Receivables turnover: 1.8243908442037904
Capitalized R&D asset: 841859.28
ROCI (R&D-adjusted, %): -77.22916202553462
FCF margin (%): -42201.53794266442
Revenue growth (%): -57.50931498996847
Rule of 40 score: -42259.04725765439
Financial ratios for COF.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.112781954887218
Shares outstanding: 597337000
Market cap (USD): 664705834.5864661
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COF.AX — annual report dated 2022-06-30
Total revenue: 115175862.06896552
Gross profit: 106439310.34482759
Operating income: 72717931.03448276
Net income: 79323448.27586207
Capital expenditures: 0
Net tangible assets: 1029311034.4827586
Owner earnings: 79323448.27586207
Return on net tangible assets (%): 7.706460498183921
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.7999999999999999
P/E ratio: 6.02431702588268
Shares outstanding: 597337000
Book value: 1029311034.4827586
P/B ratio: 0.46426161188501713
Market cap (USD): 477869599.99999994
Debt to equity: 0.5769496971861325
Current ratio: 0.6842445867002482
Quick ratio: 0.6842445867002482
Effective tax rate (%): 0
Interest coverage ratio: 5.469782642527364
COGS to revenue (%): 7.585401634681596
SG&A to revenue (%): 0.48381784976497705
Free cash flow (dilution-adjusted): 66227586.20689655
Buyback yield (%): 0.738478764341021
Retained earnings: 5463448.275862069
Receivables turnover: 22.416778523489935
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.479990006793851
FCF margin (%): 57.5012724169935
Rule of 40 score: 57.5012724169935
Financial ratios for COF.AX — annual report dated 2023-06-30
Total revenue: 110478145.69536424
Gross profit: 101743708.60927153
Operating income: 68758940.397351
Net income: -60881456.95364238
Capital expenditures: 0
Net tangible assets: 871750993.3774835
Owner earnings: -60881456.95364238
Return on net tangible assets (%): -6.983812741958029
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.6821192052980133
Shares outstanding: 597337000
Book value: 871750993.3774835
P/B ratio: 0.46739842320852304
Market cap (USD): 407455039.7350994
Debt to equity: 0.7035577326291607
Current ratio: 1.4187661380910006
Quick ratio: 1.4187661380910006
Interest coverage ratio: 2.819213641794287
COGS to revenue (%): 7.906031578568775
SG&A to revenue (%): 0.0983083765930153
Free cash flow (dilution-adjusted): 48294701.98675497
Buyback yield (%): 0
Retained earnings: -111413907.28476821
Receivables turnover: 18.535777777777778
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.629988031044367
FCF margin (%): 43.714258311253914
Revenue growth (%): -4.078733416198237
Rule of 40 score: 39.635524895055674
Financial ratios for COF.AX — annual report dated 2024-06-30
Total revenue: 107200666.66666667
Gross profit: 99180000
Operating income: 64410666.666666664
Net income: -112496666.66666667
Capital expenditures: 0
Net tangible assets: 717279333.3333334
Owner earnings: -112496666.66666667
Return on net tangible assets (%): -15.683801475761653
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.6133333333333334
Shares outstanding: 597337000
Book value: 717279333.3333334
P/B ratio: 0.5107726882785786
Market cap (USD): 366366693.3333334
Debt to equity: 0.7965608935245124
Current ratio: 0.6625233894680567
Quick ratio: 0.6625233894680567
Interest coverage ratio: 2.109013119119862
COGS to revenue (%): 7.481918644784548
Free cash flow (dilution-adjusted): 42605333.333333336
Buyback yield (%): 0
Retained earnings: -272440000
Receivables turnover: 22.021500958641468
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.998360023052799
FCF margin (%): 39.74353393324668
Revenue growth (%): -2.9666310998149665
Rule of 40 score: 36.77690283343171
Financial ratios for D6H0.DE — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 84.6046511627907
Shares outstanding: 8294703
Market cap (USD): 701770453.8139535
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for D6H0.DE — annual report dated 2022-09-30
Total revenue: 484264599.01960784
Gross profit: 124856476.84313725
Operating income: 40111039.33333333
Net income: 21595667.088235293
Capital expenditures: 5566829.705882353
Operating cash flow: 68875948.89215687
Depreciation & amortization: 34320534.48039216
Net tangible assets: -70715230.05882353
Owner earnings: 50349371.86274509
Return on net tangible assets (%): -71.20018109375114
Capex to operating income (%): 13.87854764774487
Buffett classification: The Great
Stock price: 48.97058823529412
P/E ratio: 18.809165907560374
Shares outstanding: 8294703
Book value: 124959065.70588243
P/B ratio: 3.2506363812220567
Market cap (USD): 406196485.14705884
Debt to equity: 1.025645453443958
Current ratio: 0.8511187398513073
Quick ratio: 0.8086496629861318
Effective tax rate (%): 40.034016420157116
Interest coverage ratio: 8.732901194684791
COGS to revenue (%): 74.21730246317637
SG&A to revenue (%): 3.508479178913311
Free cash flow (dilution-adjusted): 60238288.18627451
Buyback yield (%): 0
Retained earnings: 67515354.02941176
Inventory turnover: 44.34739953310545
Receivables turnover: 8.95682616570552
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.159899270969076
FCF margin (%): 12.439126937675548
Rule of 40 score: 12.439126937675548
Financial ratios for D6H0.DE — annual report dated 2023-09-30
Total revenue: 523995778.01052636
Gross profit: 136012819.17894736
Operating income: 45295890.94736842
Net income: 29752928.18947369
Capital expenditures: 11552413.315789474
Operating cash flow: 49120007.24210527
Depreciation & amortization: 36748277.07368421
Net tangible assets: -56572249.852631584
Owner earnings: 54948791.94736842
Return on net tangible assets (%): -97.13029283881725
Capex to operating income (%): 25.504329585243845
Buffett classification: The Good
Stock price: 45.10526315789474
P/E ratio: 12.574720687960536
Shares outstanding: 8294703
Book value: 155192738.76842105
P/B ratio: 2.410774915119345
Market cap (USD): 374134761.631579
Debt to equity: 1.0284607028402504
Current ratio: 0.8653822177977128
Quick ratio: 0.8382665420144507
Effective tax rate (%): 31.46311703049979
Interest coverage ratio: 5.765624083400673
COGS to revenue (%): 74.04314597813132
SG&A to revenue (%): 3.2717685610763434
Free cash flow (dilution-adjusted): 33084414.494736843
Buyback yield (%): 0
Retained earnings: 92402945.29473685
Inventory turnover: 81.08873730510345
Receivables turnover: 8.731660520248468
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.456680257215826
FCF margin (%): 6.313870432382037
Revenue growth (%): 8.204435978048812
Rule of 40 score: 14.51830641043085
Financial ratios for D6H0.DE — annual report dated 2024-09-30
Total revenue: 586176629.5333333
Gross profit: 156467306.3222222
Operating income: 49319308.58888888
Net income: 29109539.488888886
Capital expenditures: 12418261.066666668
Operating cash flow: 65437781.17777778
Depreciation & amortization: 38439025.166666664
Net tangible assets: -87860743.73333333
Owner earnings: 55130303.588888876
Return on net tangible assets (%): -62.74736730685457
Capex to operating income (%): 25.179308919720683
Buffett classification: The Good
Stock price: 46.37777777777778
P/E ratio: 13.215251742938182
Shares outstanding: 8294703
Book value: 170932503.97777778
P/B ratio: 2.25053681139942
Market cap (USD): 384689892.4666667
Debt to equity: 1.2439154326791293
Current ratio: 1.1611255660409145
Quick ratio: 1.1268924683743928
Effective tax rate (%): 32.94161989733771
Interest coverage ratio: 3.995325296757828
COGS to revenue (%): 73.30714012825982
SG&A to revenue (%): 3.4881975960519367
Free cash flow (dilution-adjusted): 42580147.07777777
Buyback yield (%): 0
Retained earnings: 112660111.71111111
Inventory turnover: 73.29399419474052
Receivables turnover: 7.084668387515165
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.581882352228652
FCF margin (%): 7.2640472056480085
Revenue growth (%): 11.866670330606713
Rule of 40 score: 19.13071753625472
Financial ratios for D6H0.DE — quarterly report dated 2024-09-30
Total revenue: 163386063.57777777
Gross profit: 73294566
Operating income: 13593333.277777776
Net income: 8728035.733333332
Capital expenditures: 5425975.5
Operating cash flow: 33210037.01111111
Depreciation & amortization: 9397362.566666666
Net tangible assets: -87860743.73333333
Owner earnings: 12699422.799999997
Return on net tangible assets (%): -14.45403517018259
Capex to operating income (%): 39.91644572468713
Buffett classification: The Good
Stock price: 46.37777777777778
P/E ratio: 11.018799195490617
Shares outstanding: 8294703
Book value: 170932503.97777778
P/B ratio: 2.25053681139942
Market cap (USD): 384689892.4666667
Debt to equity: 1.2439154326791293
Current ratio: 1.1611255660409145
Quick ratio: 1.1268924683743928
Effective tax rate (%): 33.867884597162956
Interest coverage ratio: 2.787698406414045
COGS to revenue (%): 55.14025835801528
Free cash flow (dilution-adjusted): 58366064.33333333
Buyback yield (%): 0
Retained earnings: 112660111.71111111
Inventory turnover: 15.366587001457884
Receivables turnover: 1.974722329874465
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.1921856024016857
FCF margin (%): 35.72279241891946
Rule of 40 score: 35.72279241891946
Financial ratios for D6H0.DE — quarterly report dated 2024-12-31
Total revenue: 145055011.25000003
Gross profit: 26923577.864583336
Operating income: 9610822.75
Net income: 4507072.250000001
Capital expenditures: 93113.14583333333
Operating cash flow: -406594.6458333333
Depreciation & amortization: 8718242.9375
Net tangible assets: -92421055.03125
Owner earnings: 13132202.041666666
Return on net tangible assets (%): -14.209102067950125
Capex to operating income (%): 0.9688363655789336
Buffett classification: The Great
Stock price: 47.19791666666667
P/E ratio: 21.715466230253462
Shares outstanding: 8294703
Book value: 162736018.78125006
P/B ratio: 2.4056917694108946
Market cap (USD): 391492700.96875006
Debt to equity: 0
Current ratio: 1.130041190222489
Quick ratio: 1.092490549445096
Effective tax rate (%): 38.473237417802274
Interest coverage ratio: 3.7672642780530903
COGS to revenue (%): 81.4390570635433
Free cash flow (dilution-adjusted): -2865265.3229166665
Buyback yield (%): 0.5689628958142782
Retained earnings: 110125926.94791667
Inventory turnover: 19.33002934931245
Receivables turnover: 2.1784586222824376
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.3663658042716955
FCF margin (%): -1.9752956469586747
Revenue growth (%): -11.219471187670477
Rule of 40 score: -13.194766834629151
Financial ratios for D6H0.DE — quarterly report dated 2025-03-31
Total revenue: 152735647.22826084
Gross profit: 32012553.282608695
Operating income: 14543446.054347824
Net income: 7443999.804347826
Capital expenditures: 6479774.380434782
Operating cash flow: 12715191.804347826
Depreciation & amortization: 11335359.31521739
Net tangible assets: -93083653.17391305
Owner earnings: 12299584.739130437
Return on net tangible assets (%): -13.2134744606021
Capex to operating income (%): 44.554601132498625
Buffett classification: The Good
Stock price: 42.42391304347826
P/E ratio: 11.818033585517668
Shares outstanding: 8294703
Book value: 172478781.46739125
P/B ratio: 2.040214777723294
Market cap (USD): 351893758.79347825
Debt to equity: 0
Current ratio: 1.1821137636350676
Quick ratio: 1.1298511426085573
Effective tax rate (%): 38.5142485920938
Interest coverage ratio: 5.4417073178965
COGS to revenue (%): 79.04054890685313
Free cash flow (dilution-adjusted): 4215068.380434782
Buyback yield (%): 0
Retained earnings: 113342029
Inventory turnover: 13.294629923954192
Receivables turnover: 1.7754603112811742
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3551397284620714
FCF margin (%): 2.759714877912838
Revenue growth (%): 5.294981477767328
Rule of 40 score: 8.054696355680166
Financial ratios for D6H0.DE — quarterly report dated 2025-06-30
Total revenue: 160354536.4
Gross profit: 31686519.65882353
Operating income: 12777240.752941178
Net income: 6315859.764705882
Capital expenditures: 2852565.3294117646
Operating cash flow: 2884575.564705882
Depreciation & amortization: 10249662.141176471
Net tangible assets: -93201179.47058824
Owner earnings: 13712956.576470591
Return on net tangible assets (%): -14.713286521012353
Capex to operating income (%): 22.32536260816042
Buffett classification: The Great
Stock price: 72.67058823529412
P/E ratio: 22.329382136773773
Shares outstanding: 8294703
Book value: 193478170.71764708
P/B ratio: 3.115498477224746
Market cap (USD): 602780946.2470589
Debt to equity: 0
Current ratio: 0.931345221059271
Quick ratio: 0.8586369926338712
Effective tax rate (%): 38.15017271267452
Interest coverage ratio: 3.940144683332337
COGS to revenue (%): 80.23971109879776
Free cash flow (dilution-adjusted): -2947007.541176471
Buyback yield (%): 0
Retained earnings: 128996392.36470589
Inventory turnover: 6.987479198401118
Receivables turnover: 1.7414339171591784
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.062773075589262
FCF margin (%): -1.8378074031066018
Revenue growth (%): 4.988284863423441
Rule of 40 score: 3.1504774603168393
Financial ratios for D6H0.DE — annual report dated 2025-09-30
Total revenue: 665977628.1882354
Gross profit: 181289541.42352942
Operating income: 54259942.07058823
Net income: 25820444.552941177
Capital expenditures: 14247108.77647059
Operating cash flow: 48915905.24705882
Depreciation & amortization: 43292514.776470594
Net tangible assets: -88721780.47058825
Owner earnings: 54865850.55294119
Return on net tangible assets (%): -61.8403398375549
Capex to operating income (%): 26.257139673935036
Buffett classification: The Good
Stock price: 75.24705882352941
P/E ratio: 24.172783055108535
Shares outstanding: 8294703
Book value: 200526493.36470592
P/B ratio: 3.112566295315076
Market cap (USD): 624152004.5647058
Debt to equity: 1.1506339575747755
Current ratio: 0.9677525412089987
Quick ratio: 0.9252817697846749
Effective tax rate (%): 42.03999028680167
Interest coverage ratio: 3.9209294929792717
COGS to revenue (%): 72.77843372656223
SG&A to revenue (%): 3.8094467754676904
Free cash flow (dilution-adjusted): 21258544.929411765
Buyback yield (%): 0.40305986256011495
Retained earnings: 135349147.49411765
Inventory turnover: 54.57982945728635
Receivables turnover: 6.531840293609736
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.825678760414618
FCF margin (%): 3.1920809393019343
Revenue growth (%): 13.613814443341631
Rule of 40 score: 16.805895382643566
Financial ratios for D6H0.DE — quarterly report dated 2025-09-30
Total revenue: 176482378.5529412
Gross profit: 84546334.97647059
Operating income: 14886983.423529413
Net income: 6357209.282352941
Capital expenditures: 4275977.505882353
Operating cash flow: 32728217.211764704
Depreciation & amortization: 11043833.623529412
Net tangible assets: -88721780.47058825
Owner earnings: 13125065.399999999
Return on net tangible assets (%): -14.793509925503612
Capex to operating income (%): 28.722927837240796
Buffett classification: The Good
Stock price: 75.24705882352941
P/E ratio: 25.347158383893902
Shares outstanding: 8294703
Book value: 200526493.36470592
P/B ratio: 3.112566295315076
Market cap (USD): 624152004.5647058
Debt to equity: 1.1506339575747755
Current ratio: 0.9677525412089987
Quick ratio: 0.9252817697846749
Effective tax rate (%): 50.946842558844054
Interest coverage ratio: 3.0874762856147773
COGS to revenue (%): 52.093610892087796
Free cash flow (dilution-adjusted): 22879425.17647059
Buyback yield (%): 0
Retained earnings: 135349147.49411765
Inventory turnover: 10.352747914386747
Receivables turnover: 1.7309210738507983
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.518906578510761
FCF margin (%): 12.96414144237478
Revenue growth (%): 10.057615153905429
Rule of 40 score: 23.02175659628021
Financial ratios for DBD — annual report dated 2023-12-31
Capital expenditures: 0
Net tangible assets: -439800000
Buffett classification: The Gruesome
Stock price: 28.95
Shares outstanding: 34628392
Book value: 1079200000
P/B ratio: 0.9289213754633061
Market cap (USD): 1002491948.4
Debt to equity: 1.2577835433654558
Current ratio: 1.5157635467980295
Quick ratio: 1.100703729767769
Buyback yield (%): 0
Retained earnings: 17100000
Capitalized R&D asset: 122548000
Rule of 40 score: 0
Financial ratios for DBD — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 44.66
Shares outstanding: 34628392
Market cap (USD): 1546503986.7199998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DBD — annual report dated 2024-12-31
Total revenue: 3751100000
Gross profit: 920000000
Operating income: 182800000
Net income: -14500000
Capital expenditures: 40400000
Operating cash flow: 149200000
Depreciation & amortization: 132300000
Net tangible assets: -435200000
Owner earnings: 77400000
Capex to operating income (%): 22.100656455142232
Buffett classification: The Great
Stock price: 43.04
Shares outstanding: 34628392
Book value: 938200000
P/B ratio: 1.5885802512044338
Market cap (USD): 1490405991.68
Debt to equity: 0.9883820081006182
Current ratio: 1.3171444365474216
Quick ratio: 0.9001026612966911
Effective tax rate (%): 135.94080338266386
Interest coverage ratio: 1.177076625885383
COGS to revenue (%): 75.4738610007731
R&D to revenue (%): 2.4952680547039536
SG&A to revenue (%): 17.15763376076351
Free cash flow (dilution-adjusted): 99100000
Buyback yield (%): 0
Retained earnings: -1100000
Inventory turnover: 5.36091649308843
Receivables turnover: 6.374001699235344
Capitalized R&D asset: 133431000
ROCI (R&D-adjusted, %): 8.502614737247912
FCF margin (%): 2.641891711764549
Rule of 40 score: 2.641891711764549
Financial ratios for DBD — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 43.04
Shares outstanding: 34628392
Market cap (USD): 1490405991.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DBD — quarterly report dated 2025-03-31
Total revenue: 841100000
Gross profit: 202400000
Operating income: 36400000
Net income: -7500000
Capital expenditures: 9600000
Operating cash flow: 15700000
Depreciation & amortization: 33900000
Net tangible assets: -403900000
Owner earnings: 16800000
Capex to operating income (%): 26.373626373626376
Buffett classification: The Good
Stock price: 43.72
Shares outstanding: 34628392
Book value: 991000000
P/B ratio: 1.5277026218365286
Market cap (USD): 1513953298.24
Debt to equity: 1.0647124117053481
Current ratio: 1.3456953642384106
Quick ratio: 0.9148422282820413
Interest coverage ratio: 1.6930232558139535
COGS to revenue (%): 75.93627392700036
R&D to revenue (%): 2.6988467483057903
SG&A to revenue (%): 17.239329449530377
Free cash flow (dilution-adjusted): 3100000
Buyback yield (%): 0.6341014621230513
Retained earnings: -9400000
Inventory turnover: 1.1549728752260398
Receivables turnover: 1.3957849319615
Capitalized R&D asset: 22700000
ROCI (R&D-adjusted, %): 2.1791835814163285
FCF margin (%): 0.36856497443823566
Rule of 40 score: 0.36856497443823566
Financial ratios for DBD — quarterly report dated 2025-06-30
Total revenue: 915200000
Gross profit: 234000000
Operating income: 62500000
Net income: 12700000
Capital expenditures: 17400000
Operating cash flow: 30100000
Depreciation & amortization: 31200000
Net tangible assets: -359700000
Owner earnings: 26500000
Return on net tangible assets (%): -7.367250486516541
Capex to operating income (%): 27.839999999999996
Buffett classification: The Good
Stock price: 55.4
P/E ratio: 368.92556092307694
Shares outstanding: 34628392
Book value: 1105000000
P/B ratio: 1.7361202866968326
Market cap (USD): 1918412916.8
Debt to equity: 0.9619909502262444
Current ratio: 1.3633508675512287
Quick ratio: 0.9126952971657376
Effective tax rate (%): 27.906976744186046
Interest coverage ratio: 2.86697247706422
COGS to revenue (%): 74.43181818181817
R&D to revenue (%): 2.4475524475524475
SG&A to revenue (%): 16.1604020979021
Free cash flow (dilution-adjusted): 9400000
Buyback yield (%): 1.5690052822521738
Retained earnings: 2800000
Inventory turnover: 1.186759581881533
Receivables turnover: 1.5268601935268602
Capitalized R&D asset: 37609000
ROCI (R&D-adjusted, %): 2.7904151900830563
Rosenberg metric: 1.3920704845814977
FCF margin (%): 1.027097902097902
Revenue growth (%): 8.809891808346213
Rule of 40 score: 9.836989710444115
Financial ratios for DBD — quarterly report dated 2025-09-30
Total revenue: 945200000
Gross profit: 245100000
Operating income: 73800000
Net income: 41700000
Capital expenditures: 12900000
Operating cash flow: 37400000
Depreciation & amortization: 31700000
Net tangible assets: -343000000
Owner earnings: 60500000
Return on net tangible assets (%): -17.63848396501458
Capex to operating income (%): 17.479674796747968
Buffett classification: The Great
Stock price: 57.03
P/E ratio: 42.10782933390192
Shares outstanding: 34628392
Book value: 1112400000
P/B ratio: 1.7753121141316073
Market cap (USD): 1974857195.76
Debt to equity: 0.839626033800791
Current ratio: 1.3627513059996834
Quick ratio: 0.888079784707931
Effective tax rate (%): 18.3206106870229
Interest coverage ratio: 3.385321100917431
COGS to revenue (%): 74.06898011002963
R&D to revenue (%): 2.147693609818028
SG&A to revenue (%): 15.964875158696573
Free cash flow (dilution-adjusted): 21500000
Buyback yield (%): 2.0203992514327074
Retained earnings: 43900000
Inventory turnover: 1.1674170418542604
Receivables turnover: 1.6293742458196863
Capitalized R&D asset: 42799000
ROCI (R&D-adjusted, %): 2.888304126040319
Rosenberg metric: 0.4955357142857143
FCF margin (%): 2.274650867541261
Revenue growth (%): 3.277972027972028
Rule of 40 score: 5.552622895513289
Financial ratios for DBD — annual report dated 2025-12-31
Total revenue: 3805700000
Gross profit: 961200000
Operating income: 242000000
Net income: 97500000
Capital expenditures: 61700000
Operating cash flow: 300700000
Depreciation & amortization: 127500000
Net tangible assets: -334900000
Owner earnings: 163300000
Return on net tangible assets (%): -48.76082412660496
Capex to operating income (%): 25.495867768595044
Buffett classification: The Good
Stock price: 67.89
P/E ratio: 24.112015721846152
Shares outstanding: 34628392
Book value: 1104800000
P/B ratio: 2.127915942143374
Market cap (USD): 2350921532.88
Debt to equity: 0.849475018102824
Current ratio: 1.3028071454611738
Quick ratio: 0.9229310973386803
Effective tax rate (%): 19.26458832933653
Interest coverage ratio: 2.823803967327888
COGS to revenue (%): 74.74314843524188
R&D to revenue (%): 2.2781617048112044
SG&A to revenue (%): 16.61980713140815
Free cash flow (dilution-adjusted): 226900000
Buyback yield (%): 5.55952200752042
Retained earnings: 91900000
Inventory turnover: 5.459692898272553
Receivables turnover: 6.244995077125041
Capitalized R&D asset: 149412000
ROCI (R&D-adjusted, %): 10.203957585574962
Rosenberg metric: 0.44017094017094016
FCF margin (%): 5.96210946737788
Revenue growth (%): 1.4555730319106395
Rule of 40 score: 7.41768249928852
Financial ratios for DBD — quarterly report dated 2025-12-31
Total revenue: 1104200000
Gross profit: 279800000
Operating income: 82400000
Net income: 50500000
Capital expenditures: 21800000
Operating cash flow: 217500000
Depreciation & amortization: 101400000
Net tangible assets: -334900000
Owner earnings: 130100000
Return on net tangible assets (%): -38.84741713944461
Capex to operating income (%): 26.45631067961165
Buffett classification: The Good
Stock price: 67.89
P/E ratio: 24.13677138480493
Shares outstanding: 34628392
Book value: 1104800000
P/B ratio: 2.127915942143374
Market cap (USD): 2350921532.88
Debt to equity: 0.849475018102824
Current ratio: 1.3028071454611738
Quick ratio: 0.9229310973386803
Effective tax rate (%): 18.949044585987263
Interest coverage ratio: 4
COGS to revenue (%): 74.66038761094005
R&D to revenue (%): 1.9380547002354647
SG&A to revenue (%): 15.902916138380728
Free cash flow (dilution-adjusted): 192900000
Buyback yield (%): 2.1736157198492227
Retained earnings: 91900000
Inventory turnover: 1.5823416506717851
Receivables turnover: 1.8119461765671152
Capitalized R&D asset: 42393000
ROCI (R&D-adjusted, %): 3.26430767967651
Rosenberg metric: 1.70935960591133
FCF margin (%): 17.469661293243977
Revenue growth (%): 16.821836648328397
Rule of 40 score: 34.29149794157237
Financial ratios for DECCANCE.NS — annual report dated 2022-03-31
Total revenue: 104163523.67137018
Gross profit: 82866860.08176184
Operating income: 17921970.196492154
Net income: 11548780.16616115
Capital expenditures: 5502030.858499275
Operating cash flow: 11124357.114598444
Depreciation & amortization: 3415125.939601741
Net tangible assets: 84865356.71897666
Owner earnings: 9461875.247263618
Return on net tangible assets (%): 11.149278825982778
Capex to operating income (%): 30.699921929209438
Buffett classification: The Good
Stock price: 7.167743637082949
P/E ratio: 8.693746659982827
Shares outstanding: 14007500
Book value: 85131280.49584597
P/B ratio: 1.1793804628762583
Market cap (USD): 100402168.99643941
Debt to equity: 0.25064204891793906
Current ratio: 1.7972529350209394
Quick ratio: 1.4586176375071374
Effective tax rate (%): 25.324265026276322
Interest coverage ratio: 14.764286024682773
COGS to revenue (%): 20.445413940486556
SG&A to revenue (%): 22.373726375919134
Free cash flow (dilution-adjusted): 5556191.480944217
Buyback yield (%): 0
Retained earnings: 76440735.85652117
Inventory turnover: 2.0245007151892147
Receivables turnover: 33.496261805104986
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.134255536024977
FCF margin (%): 5.334104766341888
Rule of 40 score: 5.334104766341888
Financial ratios for DECCANCE.NS — annual report dated 2023-03-31
Total revenue: 95026175.39585872
Gross profit: 77949415.34713764
Operating income: 8540158.343483558
Net income: 6004275.2740560295
Capital expenditures: 27731863.580998782
Operating cash flow: 6693495.736906213
Depreciation & amortization: 3336552.9841656517
Net tangible assets: 83564689.40316688
Owner earnings: -18391035.3227771
Return on net tangible assets (%): -22.00814178109077
Capex to operating income (%): 324.72306092730906
Buffett classification: The Gruesome
Stock price: 5.003410475030451
P/E ratio: 11.672561471626999
Shares outstanding: 14007500
Book value: 83733800.24360538
P/B ratio: 0.8370009724279933
Market cap (USD): 70085272.22898905
Debt to equity: 0.381290398128167
Current ratio: 1.5754087970995407
Quick ratio: 1.1244395836458088
Effective tax rate (%): 25.99522298969985
Interest coverage ratio: 6.119652972340779
COGS to revenue (%): 17.970585449306935
SG&A to revenue (%): 23.974790457760914
Free cash flow (dilution-adjusted): -21939269.18392205
Buyback yield (%): 0
Retained earnings: 75706954.93300854
Inventory turnover: 1.2368503236802684
Receivables turnover: 27.655811101106707
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.757157824512569
FCF margin (%): -23.087606222735733
Revenue growth (%): -8.772119023487779
Rule of 40 score: -31.859725246223512
Financial ratios for DECCANCE.NS — annual report dated 2024-03-31
Total revenue: 95747751.5289603
Gross profit: 76641527.76112244
Operating income: 8157261.062477515
Net income: 4468485.429907663
Capital expenditures: 34210492.8648519
Operating cash flow: 6799292.481112843
Depreciation & amortization: 3313898.548986689
Net tangible assets: 86127185.51385058
Owner earnings: -26428108.885957547
Return on net tangible assets (%): -30.684979113485017
Capex to operating income (%): 419.38700506002345
Buffett classification: The Gruesome
Stock price: 7.051823416506719
P/E ratio: 22.105569785590422
Shares outstanding: 14007500
Book value: 86218359.51552942
P/B ratio: 1.1456772903331123
Market cap (USD): 98778416.50671786
Debt to equity: 0.7233995234047811
Current ratio: 1.4648954694565122
Quick ratio: 1.1064544729142654
Effective tax rate (%): 30.31688000822822
Interest coverage ratio: 6.219054845994203
COGS to revenue (%): 19.954749289396016
SG&A to revenue (%): 21.117190322885676
Free cash flow (dilution-adjusted): -27523348.12327617
Buyback yield (%): 0
Retained earnings: 78315685.3339729
Inventory turnover: 1.576378678834962
Receivables turnover: 14.760241431582061
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.843596843584558
FCF margin (%): -28.745686121883846
Revenue growth (%): 0.7593446017327865
Rule of 40 score: -27.98634152015106
Financial ratios for DECCANCE.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 82646404.68227425
Buffett classification: The Gruesome
Stock price: 7.142498805542284
Shares outstanding: 14007500
Book value: 85228320.59245102
P/B ratio: 1.1738885774489285
Market cap (USD): 100048552.01863354
Debt to equity: 0.8565205600593667
Current ratio: 1.153749073466887
Quick ratio: 0.8346393420659046
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DECCANCE.NS — quarterly report dated 2024-12-31
Total revenue: 13456708.241053734
Gross profit: 11396642.96538058
Operating income: 195302.48280685392
Net income: 94288.3785989043
Capital expenditures: 0
Depreciation & amortization: 823720.7133698566
Owner earnings: 918009.0919687608
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.425107821424408
P/E ratio: 275.76886821609594
Shares outstanding: 14007500
Market cap (USD): 104007197.8086024
Effective tax rate (%): 45.222455475045706
Interest coverage ratio: 0.47745924997150346
COGS to revenue (%): 15.308835108636053
SG&A to revenue (%): 17.53664728949085
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DECCANCE.NS — quarterly report dated 2025-03-31
Total revenue: 13902244.56394669
Gross profit: 12934708.908113163
Operating income: 728735.0946925414
Net income: 929471.5922375496
Capital expenditures: 0
Depreciation & amortization: 805225.6254383913
Net tangible assets: 84439256.48819265
Owner earnings: 1734697.217675941
Return on net tangible assets (%): 2.054372918262856
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.085891002450696
P/E ratio: 34.23198171943187
Shares outstanding: 14007500
Book value: 84454711.24620059
P/B ratio: 1.506968839734843
Market cap (USD): 127270618.21682812
Debt to equity: 0.9885420727061722
Current ratio: 1.1681445051584418
Quick ratio: 0.828843172440116
Effective tax rate (%): 23.592104251556854
Interest coverage ratio: 2.218678815489749
COGS to revenue (%): 6.959564345045989
SG&A to revenue (%): 17.697641603837212
Buyback yield (%): 0
Retained earnings: 76750666.35492167
Inventory turnover: 0.08224436702156203
Receivables turnover: 2.060126982477111
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.46911064865970914
Revenue growth (%): 3.310886398901879
Rule of 40 score: 3.310886398901879
Financial ratios for DECCANCE.NS — annual report dated 2025-03-31
Total revenue: 61605938.74210895
Gross profit: 53665454.75800794
Operating income: 852642.0388122515
Net income: 878945.5225625437
Capital expenditures: 27988578.44283376
Operating cash flow: -4400514.379237783
Depreciation & amortization: 3282335.7493570256
Net tangible assets: 84439256.48819265
Owner earnings: -23827297.170914188
Return on net tangible assets (%): -28.218269750215075
Capex to operating income (%): 3282.5707822033314
Buffett classification: The Gruesome
Stock price: 9.085891002450696
P/E ratio: 144.79921104299368
Shares outstanding: 14007500
Book value: 84454711.24620059
P/B ratio: 1.506968839734843
Market cap (USD): 127270618.21682812
Debt to equity: 0.9885420727061722
Current ratio: 1.1681445051584418
Quick ratio: 0.828843172440116
Effective tax rate (%): 30.00055861760763
Interest coverage ratio: 0.57196295395908
COGS to revenue (%): 12.889153458631608
SG&A to revenue (%): 18.523325107803526
Free cash flow (dilution-adjusted): -36909317.27846621
Buyback yield (%): 0
Retained earnings: 76750666.35492167
Inventory turnover: 0.6749726226416219
Receivables turnover: 9.129177385685454
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5488736069044515
FCF margin (%): -59.91194685462673
Revenue growth (%): -35.65808307939708
Rule of 40 score: -95.57002993402381
Financial ratios for DECCANCE.NS — quarterly report dated 2025-06-30
Total revenue: 17617540.369763635
Gross profit: 15636168.967938218
Operating income: 2480107.6527030193
Net income: 1796126.8429674702
Capital expenditures: 0
Depreciation & amortization: 782014.9777673766
Owner earnings: 2578141.820734847
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.725953662532179
P/E ratio: 53.28008031827565
Shares outstanding: 14007500
Market cap (USD): 150243795.9279195
Effective tax rate (%): 24.991692728694293
Interest coverage ratio: 6.108597285067874
COGS to revenue (%): 11.246583576592641
SG&A to revenue (%): 18.718513278803396
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 26.724431358746102
Rule of 40 score: 26.724431358746102
Financial ratios for DECCANCE.NS — quarterly report dated 2025-09-30
Total revenue: 15818692.22096956
Gross profit: 12822953.776775647
Operating income: 1511657.2717023676
Net income: 1022480.2705749718
Capital expenditures: 0
Depreciation & amortization: 760281.848928974
Net tangible assets: 81780800.45095828
Owner earnings: 1782762.1195039458
Return on net tangible assets (%): 2.1799274520099856
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 12.470124013528746
P/E ratio: 45.46032648198669
Shares outstanding: 14007500
Book value: 84103878.24126267
P/B ratio: 2.0768990178838806
Market cap (USD): 174675262.11950392
Debt to equity: 1.0190161841519334
Current ratio: 1.0222961205775165
Quick ratio: 0.7423875599946822
Effective tax rate (%): 27.245160721018475
Interest coverage ratio: 4.106581727971578
COGS to revenue (%): 18.937965302989486
SG&A to revenue (%): 19.522734367316218
Buyback yield (%): 0
Inventory turnover: 0.28618293513005866
Receivables turnover: 2.1505240216168495
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9796179355620876
Revenue growth (%): -10.210552160172002
Rule of 40 score: -10.210552160172002
Financial ratios for DECCANCE.NS — quarterly report dated 2025-12-31
Total revenue: 14576161.301102819
Gross profit: 12879291.522780439
Operating income: 360064.6095577587
Net income: -62114.29207975939
Capital expenditures: 0
Depreciation & amortization: 908187.5905090788
Owner earnings: 846073.2984293194
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.28617578255542
P/E ratio: 31.4893455950724
Shares outstanding: 14007500
Market cap (USD): 116068607.27414504
Interest coverage ratio: 0.5872531385694301
COGS to revenue (%): 11.641403681461702
SG&A to revenue (%): 20.94677730718027
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -7.85482707742185
Rule of 40 score: -7.85482707742185
Financial ratios for DIN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 61.97
Shares outstanding: 12685175
Market cap (USD): 786100294.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DIN — annual report dated 2022-12-31
Total revenue: 909402000
Gross profit: 377358000
Operating income: 176053000
Net income: 81111000
Capital expenditures: 18290000
Operating cash flow: 89336000
Depreciation & amortization: 37952000
Net tangible assets: -1152084000
Owner earnings: 100773000
Return on net tangible assets (%): -8.747018446571603
Capex to operating income (%): 10.388916973865825
Buffett classification: The Great
Stock price: 54.31
P/E ratio: 8.493692030057575
Shares outstanding: 12685175
Book value: -301084000
Market cap (USD): 688931854.25
Debt to equity: -5.7869830346348525
Current ratio: 1.0192087899014706
Quick ratio: 1.0192087899014706
Effective tax rate (%): 29.336585790826327
Interest coverage ratio: 2.888387583672398
COGS to revenue (%): 58.504819650715525
SG&A to revenue (%): 20.97488239524435
Free cash flow (dilution-adjusted): 37887000
Buyback yield (%): 17.900028753097825
Retained earnings: 84538000
Receivables turnover: 7.5795500954317765
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.479222324845528
FCF margin (%): 4.1661443454050024
Rule of 40 score: 4.1661443454050024
Financial ratios for DIN — annual report dated 2023-12-31
Total revenue: 831100000
Gross profit: 396700000
Operating income: 187700000
Net income: 97200000
Capital expenditures: 37200000
Operating cash flow: 131200000
Depreciation & amortization: 35600000
Net tangible assets: -1091074000
Owner earnings: 95600000
Return on net tangible assets (%): -8.762008809668272
Capex to operating income (%): 19.81885988279169
Buffett classification: The Great
Stock price: 43.27
P/E ratio: 5.646990969650206
Shares outstanding: 12685175
Book value: -250974000
Market cap (USD): 548887522.25
Debt to equity: -6.318236151951995
Current ratio: 0.7770147594103186
Quick ratio: 0.7770147594103186
Effective tax rate (%): 12.981199641897941
Interest coverage ratio: 2.6814285714285715
COGS to revenue (%): 52.268078450246655
SG&A to revenue (%): 23.835880158825653
Free cash flow (dilution-adjusted): 82000000
Buyback yield (%): 5.556693997155262
Retained earnings: 150008000
Receivables turnover: 6.496166081743358
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.665953033008162
FCF margin (%): 9.866442064733485
Revenue growth (%): -8.610273564386267
Rule of 40 score: 1.2561685003472185
Financial ratios for DIN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28.37
Shares outstanding: 12685175
Market cap (USD): 359878414.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DIN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 27.81
Shares outstanding: 12685175
Market cap (USD): 352774716.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DIN — annual report dated 2024-12-31
Total revenue: 812300000
Gross profit: 375300000
Operating income: 167800000
Net income: 64900000
Capital expenditures: 11100000
Operating cash flow: 108200000
Depreciation & amortization: 39200000
Net tangible assets: -1040600000
Owner earnings: 93000000
Return on net tangible assets (%): -8.937151643282721
Capex to operating income (%): 6.615017878426698
Buffett classification: The Great
Stock price: 27.81
P/E ratio: 5.435665897534668
Shares outstanding: 12685175
Book value: -216000000
Market cap (USD): 352774716.75
Debt to equity: -7.421759259259259
Current ratio: 0.8668313496519201
Quick ratio: 0.8668313496519201
Effective tax rate (%): 27.59776536312849
Interest coverage ratio: 2.3273231622746184
COGS to revenue (%): 53.79785793426074
SG&A to revenue (%): 24.215191431737043
Free cash flow (dilution-adjusted): 78100000
Buyback yield (%): 4.1953119929760385
Retained earnings: 183600000
Receivables turnover: 7.051215277777778
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.47305433732253
FCF margin (%): 9.614674381386187
Revenue growth (%): -2.2620623270364577
Rule of 40 score: 7.35261205434973
Financial ratios for DIN — quarterly report dated 2025-03-31
Total revenue: 214800000
Gross profit: 90300000
Operating income: 36300000
Net income: 8200000
Capital expenditures: 2300000
Operating cash flow: 16100000
Depreciation & amortization: 10400000
Net tangible assets: -1034630000
Owner earnings: 16300000
Return on net tangible assets (%): -1.575442428694316
Capex to operating income (%): 6.336088154269973
Buffett classification: The Great
Stock price: 21.95
P/E ratio: 8.489011928353658
Shares outstanding: 12685175
Book value: -215746000
Market cap (USD): 278439591.25
Debt to equity: -7.586889212314481
Current ratio: 0.8684331736113958
Quick ratio: 0.8684331736113958
Effective tax rate (%): 35.9375
Interest coverage ratio: 2.0508474576271185
COGS to revenue (%): 57.960893854748605
SG&A to revenue (%): 23.88268156424581
Free cash flow (dilution-adjusted): 9300000
Buyback yield (%): 0.5746309254431503
Retained earnings: 183857000
Receivables turnover: 2.3565292755976346
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6855846251389957
FCF margin (%): 4.329608938547486
Rule of 40 score: 4.329608938547486
Financial ratios for DIN — quarterly report dated 2025-06-30
Total revenue: 230784000
Gross profit: 92229000
Operating income: 38766000
Net income: 13814000
Capital expenditures: 5863000
Operating cash flow: 37005000
Depreciation & amortization: 10420000
Net tangible assets: -1031515000
Owner earnings: 18371000
Return on net tangible assets (%): -1.7809726470288847
Capex to operating income (%): 15.124077800134138
Buffett classification: The Great
Stock price: 23.39
P/E ratio: 13.478070466521304
Shares outstanding: 12685175
Book value: -212545000
Market cap (USD): 296706243.25
Debt to equity: -7.717838575360512
Current ratio: 0.8597138067047423
Quick ratio: 0.8597138067047423
Effective tax rate (%): 27.029739580582113
Interest coverage ratio: 2.1779875273891793
COGS to revenue (%): 60.036657653910154
SG&A to revenue (%): 21.998492096505824
Free cash flow (dilution-adjusted): 27926000
Buyback yield (%): 2.63526642188376
Retained earnings: 189849000
Receivables turnover: 2.5298882957148963
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8531684698608966
FCF margin (%): 12.100492235163616
Revenue growth (%): 7.4413407821229045
Rule of 40 score: 19.54183301728652
Financial ratios for DIN — quarterly report dated 2025-09-30
Total revenue: 216166000
Gross profit: 84553000
Operating income: 31448000
Net income: 7326000
Capital expenditures: 12072000
Operating cash flow: 30197000
Depreciation & amortization: 10558000
Net tangible assets: -1047716000
Owner earnings: 5812000
Return on net tangible assets (%): -0.5547304803973596
Capex to operating income (%): 38.38717883490206
Buffett classification: The Good
Stock price: 24.28
P/E ratio: 10.497479516019087
Shares outstanding: 12685175
Book value: -231918000
Market cap (USD): 307996049
Debt to equity: -7.016109142024336
Current ratio: 1.0541119049719208
Quick ratio: 1.0541119049719208
Effective tax rate (%): 27.205882352941174
Interest coverage ratio: 1.5125775575970373
COGS to revenue (%): 60.88515307680209
SG&A to revenue (%): 23.222893517019326
Free cash flow (dilution-adjusted): 13528000
Buyback yield (%): 7.309834029721596
Retained earnings: 189846000
Receivables turnover: 2.393096347795282
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.193411952449105
FCF margin (%): 6.258153456140189
Revenue growth (%): -6.334061286744315
Rule of 40 score: -0.07590783060412587
Financial ratios for DIN — annual report dated 2025-12-31
Total revenue: 879400000
Gross profit: 359300000
Operating income: 143600000
Net income: 17100000
Capital expenditures: 34500000
Operating cash flow: 89000000
Depreciation & amortization: 42900000
Net tangible assets: -1057900000
Owner earnings: 25500000
Return on net tangible assets (%): -2.4104357689762734
Capex to operating income (%): 24.02506963788301
Buffett classification: The Great
Stock price: 31.74
P/E ratio: 23.545465175438594
Shares outstanding: 12685175
Book value: -273900000
Market cap (USD): 402627454.5
Debt to equity: -5.84118291347207
Current ratio: 0.962253829321663
Quick ratio: 0.962253829321663
Effective tax rate (%): 32.142857142857146
Interest coverage ratio: 1.841025641025641
COGS to revenue (%): 59.13122583579713
SG&A to revenue (%): 23.174891971798953
Free cash flow (dilution-adjusted): 40200000
Buyback yield (%): 15.572708542159289
Retained earnings: 175100000
Receivables turnover: 7.389915966386555
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.465709496392392
FCF margin (%): 4.57129861269047
Revenue growth (%): 8.260494891050104
Rule of 40 score: 12.831793503740574
Financial ratios for DIN — quarterly report dated 2025-12-31
Total revenue: 217670000
Gross profit: 92208000
Operating income: 37129000
Net income: -12087000
Capital expenditures: 12785000
Operating cash flow: 5698000
Depreciation & amortization: 11522000
Net tangible assets: -1057900000
Owner earnings: -13350000
Capex to operating income (%): 34.434000377063754
Buffett classification: The Good
Stock price: 31.74
P/E ratio: 23.33666344983481
Shares outstanding: 12685175
Book value: -273900000
Market cap (USD): 402627454.5
Debt to equity: -5.84118291347207
Current ratio: 0.962253829321663
Quick ratio: 0.962253829321663
Interest coverage ratio: 1.7123553013881843
COGS to revenue (%): 57.59268617632195
SG&A to revenue (%): 23.656911839022374
Free cash flow (dilution-adjusted): -10554000
Buyback yield (%): 7.641555402178865
Retained earnings: 175100000
Receivables turnover: 1.8291596638655463
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.705998105094381
FCF margin (%): -4.848624063950016
Revenue growth (%): 0.6957615906294237
Rule of 40 score: -4.152862473320592
Financial ratios for DTSQ — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.99
Shares outstanding: 3653409
Market cap (USD): 36497555.910000004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0